EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING. FMHR [Internet]. 2026 Mar. 31 [cited 2026 Nov. 9];4(3):3863-74. Available from: https://fmhr.net/index.php/fmhr/article/view/3740